CorVel Announces Earnings Release Webcast

IRVINE, Calif., July 26, 2017 (GLOBE NEWSWIRE) -- In conjunction with CorVel Corporation’s (NASDAQ: CRVL)  quarterly earnings release, CorVel will be conducting a webcast that will be broadcast over the internet on Tuesday, August 1st at 11:30 am Eastern Time.

Event:			Quarterly Earnings Release
Host:			Gordon ClemonsChief Executive Officer
Date:			Tuesday, August 1, 2017
Time:			11:30 am Eastern Time
Login:			www.corvel.com
Contact:			Investor Relations 1-949-851-1473

About CorVel

CorVel Corporation is a national provider of innovative workers’ compensation, auto, liability and health solutions for employers, third party administrators, insurance companies, and government agencies seeking to control costs and promote positive outcomes. We apply technology, intelligence, and a human touch throughout the risk management process so our clients can intervene early and often while being connected to the critical intelligence they need to proactively manage risk. With a robust technology platform at its core, our connected solution is delivered by a national team of associates who are committed to helping clients design and administer programs that meet their organization’s performance goals.

This press release contains forward-looking statements that are subject to risks and uncertainties, including the risk that the historical financial performance of the Company may not be indicative of future financial performance and the risk that the recent performance of the Company’s Common Stock may not be indicative of its future performance, as well as other risks detailed from time to time in the Company’s SEC reports, including the report on Form 10-K for the year ended March 31, 2017 and the Company’s most recent Form 10-Q.

(Minimum requirements to listen to broadcast: Windows Media Player and a broadband Internet connection.)

Contact:  Heather Burnham
Phone:  949-851-1473
http://www.corvel.com

Source: CorVel Corporation

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Nebius Group closes $5.75B convertible notes offering
• GRI Bio to present Phase 2a IPF drug data at ERS Congress in September
• Savara to present IMPALA-2 trial data at ERS Congress in Barcelona